Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of High Cut-off Hemodialysis on Central Memory CD4+ T Cells and Regulatory T Cells in Patients With End-stage Kidney Disease

NCT01103076 is registered in ClinicalTrials.gov with Centre Hospitalier du Centre du Valais as lead sponsor.

NCT NCT01103076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01103076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of High Cut-off Hemodialysis on Central Memory CD4+ T Cells and Regulatory T Cells in Patients With End-stage Kidney Disease
Lead sponsor
Centre Hospitalier du Centre du Valais
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2011
Completion date
February 29, 2012
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd4 t cells, central memory t cells, end-stage kidney disease, regulatory t cells, uremic toxins